Skip to main content
Drug Development
Our Pipeline
Evaluation Pipeline
Inaphaea BioLabs
Therapeutic areas
Partnering
Useful Links
News
Investors
Regulatory News
AIM Rule 26
Annual and Half Yearly Reports
Admission Document & Articles
Investments Calculator
Share Alerts
Share Series
Share price look-up
Analyst Research
About us
Board of Directors and Management Team
Strategy and Vision
How we work
Working with us
Collaborative Pipeline
Contact Us
Search
Annual and Half Yearly Reports
Breadcrumb
Investors
AIM Rule 26
Annual and Half Yearly Reports
ValiRx Half Yearly Report For The Period Ended 30 June 2024
200.83 KB
ValiRx Report & Accounts For the Year Ended December 2023
1.02 MB
ValiRx Half Yearly Report For The Period Ended 30 June 2023
328.36 KB
ValiRx Report & Accounts For the Year Ended December 2022
789.66 KB
Half Yearly Report For the Period Ended 30 June 2022.
357.53 KB
Valirx Annual Reports & Accounts For The Year Ended December 2021
2.29 MB
Half Yearly Report For the Period Ended 30 June 2021 & Investor Presentation
3.85 MB
Report & Accounts For The Year Ended 31 December 2020
5.29 MB
Half Yearly Report For The Period Ended 30 June 2020
301.29 KB
Reports & Accounts For The Year Ended 31 December 2019
279.65 KB
Half Yearly Report For The Period Ended 30 June 2019
273.2 KB
Report & Accounts For The Year Ended 31 December 2018
2.66 MB
Pagination
Page
1
Page
2
Next page
››
Last page
Last »